Emerging Treatment Approaches for EBC
William J. Gradishar, MD
Applying Current Guidelines in the First-Line Treatment of MSI-H/dMMR mCRC—A Case Discussion
Aparna R. Parikh, MD
Guideline-Based, Biomarker-Directed Treatment Options in Second-Line Recurrent Endometrial Cancer
Nicoletta Colombo, MD
Susana Campos, MD, MPH
Guideline Recommendations for Biomarker-Directed Therapies in Cervical Cancer
Ritu Salani, MD, MBA
Managing Adverse Effects of Oral vs Injectable ADT in Advanced Prostate Cancer
Tanya Dorff, MD
Recent Advances in ADT: New Insights in Advanced Prostate Cancer Treatment
Rana McKay, MD
Clinical evidence driving guideline recommendations for frontline immunotherapy-based combination regimens in metastatic urothelial cancer
Ignacio Duran, MD
Wenxin Xu, MD
Implementing Guideline-Concordant Care Into the Management of Frontline Patients With Recurrent Endometrial Cancer
Agonists vs Antagonists: Evaluating ADT Efficacy as Monotherapy and Combination Therapy in Hormone-Sensitive Prostate Cancer
Testosterone Revisited: Importance of Monitoring and Impact of Rebound on Quality of Life in Advanced Prostate Cancer
Incorporation of guideline recommendations into the frontline care of a patient with mCRPC who is naïve to both docetaxel and novel hormone therapy
Sandy Srinivas, MD
Best Practices in Shared Decision Making: Selection of the Optimal ADT Regimen in mHSPC Based on Patient Preferences
Innovations in Oncology Learning Center From Guidelines to Practice: Genitourinary Cancers
First-Line Maintenance Therapy Using PARP Inhibitors for Ovarian Cancer
Advancing Prostate Cancer Care: Integrating Guideline Updates and Patient Preferences for Optimal ADT Management of Advanced Prostate Cancer
Innovations in Oncology Learning Center From Guidelines to Practice: Gynecologic Cancer
Loading...
We're glad to see you're enjoying Prova Education… but how about a more personalized experience?
Press cancel to remain on Prova Education. Press the link below or the continue button to keep going.